Klaus Eyer.

Klaus Eyer

Associate professor of biomedicine
Aarhus University

Klaus Eyer is associate professor of biomedicine at Aarhus University, where he investigates how single-cell diversity and complexity shape immune responses and their outcomes. His lab develops high-resolution single-cell technologies to measure cellular function and phenotype within complex immune environments, capturing dynamic behaviors and revealing how complex immune outcomes emerge from individual cells with diverse functionality, metabolism, gene expression and plasticity—concepts that parallel variability and population dynamics in neural systems. More recently, Eyer’s work has expanded to explore diseases at the neuro-immune interface. 

Eyer trained in pharmaceutical sciences and bioanalytics at ETH Zurich and completed postdoctoral work in microfluidics and single-cell analysis at ESPCI Paris, as well as a visiting fellowship in B cell immunology at the Institut Pasteur.  

He coordinates the TRANSCEND doctoral network and actively engages in translational initiatives through patents, spinoffs, mentoring and teaching. At Aarhus University, he established doctoral courses on measurement and data translation, training the next generation of scientists to integrate fundamental research with clinical and biomedical translation.

Explore more from The Transmitter

Two opposing arrows

European Research Council backtracks on stricter grant resubmission rules

The swift reversal came after more than 1,000 scientists signed an open letter protesting the rules last week.

By Lauren Schenkman
1 May 2026 | 4 min read
leech illustration

What leeches reveal about movement

After encountering setbacks in her study of the neuromuscular system in vertebrates, Lidia Szczupak turned to leeches to explore how the nervous system coordinates movement.

By Claudia López Lloreda
1 May 2026 | 5 min read

Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion

The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.

By Sarah DeWeerdt
30 April 2026 | 0 min watch